ANTONAZZO, IPPAZIO COSIMO
 Distribuzione geografica
Continente #
AS - Asia 4.427
NA - Nord America 2.989
EU - Europa 2.723
SA - Sud America 593
AF - Africa 80
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.817
Nazione #
US - Stati Uniti d'America 2.878
SG - Singapore 1.511
VN - Vietnam 938
IT - Italia 933
CN - Cina 757
HK - Hong Kong 712
RU - Federazione Russa 595
BR - Brasile 484
DE - Germania 370
IE - Irlanda 203
KR - Corea 127
SE - Svezia 120
GB - Regno Unito 118
ID - Indonesia 101
FR - Francia 78
IN - India 76
FI - Finlandia 64
NL - Olanda 64
CA - Canada 55
AR - Argentina 49
MX - Messico 37
ZA - Sudafrica 36
AT - Austria 33
PL - Polonia 31
BD - Bangladesh 30
ES - Italia 26
JP - Giappone 21
TR - Turchia 21
IQ - Iraq 19
UA - Ucraina 19
EC - Ecuador 16
CZ - Repubblica Ceca 14
IR - Iran 12
MA - Marocco 12
AE - Emirati Arabi Uniti 11
CO - Colombia 11
EG - Egitto 11
PH - Filippine 11
PK - Pakistan 11
SA - Arabia Saudita 10
VE - Venezuela 8
AL - Albania 7
CH - Svizzera 7
CL - Cile 7
IL - Israele 7
PY - Paraguay 7
UZ - Uzbekistan 7
KE - Kenya 6
NP - Nepal 6
DO - Repubblica Dominicana 5
LT - Lituania 5
MY - Malesia 5
PE - Perù 5
PT - Portogallo 5
TN - Tunisia 5
AU - Australia 4
CR - Costa Rica 4
DZ - Algeria 4
HN - Honduras 4
JO - Giordania 4
QA - Qatar 4
TW - Taiwan 4
BE - Belgio 3
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
ET - Etiopia 3
LB - Libano 3
LU - Lussemburgo 3
OM - Oman 3
RO - Romania 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
CG - Congo 2
GT - Guatemala 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
NO - Norvegia 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
BB - Barbados 1
BY - Bielorussia 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
NG - Nigeria 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.817
Città #
Singapore 914
Hong Kong 711
Ashburn 392
Ann Arbor 345
Ho Chi Minh City 293
Hefei 277
Hanoi 250
Milan 231
Frankfurt am Main 199
Dublin 194
Dallas 166
New York 152
Chandler 125
Seoul 125
Santa Clara 112
Los Angeles 103
Beijing 96
Jakarta 75
The Dalles 67
Munich 63
São Paulo 61
Moscow 60
Rome 60
Buffalo 54
Chicago 46
London 46
Nuremberg 43
Fairfield 42
Princeton 40
Seattle 40
Helsinki 35
Bologna 33
Wilmington 32
Boardman 31
Ha Long 31
Haiphong 28
Da Nang 27
Altamura 25
Warsaw 24
Biên Hòa 23
Rio de Janeiro 23
Verona 23
Houston 22
Shanghai 22
Perugia 21
Can Tho 20
Ninh Bình 20
Thái Nguyên 20
Parma 19
Tokyo 19
Lawrence 18
Salt Lake City 18
Lappeenranta 17
Toronto 17
Woodbridge 17
Florence 16
Turin 16
Johannesburg 15
Quận Bình Thạnh 15
San Diego 15
Washington 15
Brooklyn 14
Mexico City 14
Vienna 14
Cambridge 13
Guangzhou 13
Naples 13
Osasco 13
Phoenix 13
Hangzhou 12
Kent 12
Palermo 12
Atlanta 11
Bắc Giang 11
Denver 11
Hải Dương 11
Montreal 11
Redondo Beach 11
Stockholm 11
Turku 11
Chennai 10
Council Bluffs 10
Phủ Lý 10
Poplar 10
Vũng Tàu 10
Belo Horizonte 9
Elk Grove Village 9
Lấp Vò 9
Pavia 9
Quận Một 9
Roubaix 9
Slough 9
Amsterdam 8
Bergamo 8
Boston 8
Curitiba 8
Pune 8
Tampa 8
Baghdad 7
Berlin 7
Totale 6.465
Nome #
Epidemiology of SLE in Italy: an observational study using a primary care database 497
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 438
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 425
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 325
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 273
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy 266
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 215
PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study 210
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 208
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 196
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 196
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 193
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 192
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 180
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view 179
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 173
Azithromycin use and covid-19: a real-world observational study. 171
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 169
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 166
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy 161
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review 160
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 160
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 158
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) 157
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 156
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up 154
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 153
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy 151
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 149
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 148
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 145
The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey 145
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 141
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 139
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 136
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 134
Risk management and drug utilization research 126
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy 126
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients 126
A Multidatabase study of trajectories of antidepressant use in Italy 126
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 124
Analisi della variazione del burden dell’inquinamento atmosferico in Italia dal 1990 al 2019: evidenze dai dati del Global Burden of Disease Study 121
Impact of covid-19 lockdown, during the two waves, on drug use and emergency department access in people with epilepsy: An interrupted time-series analysis 118
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy 114
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 114
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 108
Raphanus sativus cv. Sango sprout juice decreases diet-induced obesity in sprague dawley rats and ameliorates related disorders 106
Time trends in the incidence of essential tremor: Evidences from UK and France primary care data 103
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies 102
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region 97
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 89
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months 89
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply 87
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system 86
Impatto dell’epidemia SARS-COV2 sulla gestione dei pazienti affetti da epilessia: un’analisi delle serie storiche interrotte sull’uso degli antiepilettici e l’accesso in pronto soccorso durante le due ondate COVID-19 85
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 84
Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis 82
Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice 81
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems 81
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 81
Editorial: Overcoming boundaries in public health: Advances in international and global health 81
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research 78
Diabetes is associated with decreased migraine risk: A nationwide cohort study 76
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 76
Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study 76
Drug-induced Kounis syndrome: A matter of pharmacovigilance 73
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System 73
The Burden of Chronic Heart Failure in Primary Care in Italy 73
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 72
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution 70
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 69
Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology 68
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? 67
Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system 67
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 66
Hepatitis B vaccination and the putative risk of central demyelinating diseases – A systematic review and meta-analysis 64
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements 64
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 61
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 58
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 58
Timing of hepatitis B and C virus elimination in Europe: a picture from the Global Burden of Disease Study 2019 53
Totale 11.118
Categoria #
all - tutte 45.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021275 0 0 0 0 0 68 31 34 33 34 30 45
2021/2022451 51 44 42 39 49 20 46 23 21 32 37 47
2022/2023834 44 211 69 45 71 72 158 39 41 25 24 35
2023/20241.358 42 80 71 123 162 262 139 64 127 44 105 139
2024/20253.445 173 332 133 189 287 180 249 120 368 490 328 596
2025/20264.691 1.310 790 581 878 816 316 0 0 0 0 0 0
Totale 11.118